美国医疗服务公司Amedisys 2024年Q4调整后每股收益$0.96低于预期$1.05,销售额$5.98052亿低于预期$5.98576亿

财报速递2025-02-27
美国医疗服务公司Amedisys(NASDAQ:AMED)公布2024年第4季度每股收益为$0.96,低于分析师预期的$1.05,差距为8.57%。与去年同期的每股收益$0.94相比增长了2.13%。公司本季度销售额为$5.98052亿,低于分析师预期的$5.98576亿,差距为0.09%。相比去年同期的销售额$5.70788亿,增长了4.78%。

以上内容来自Benzinga Earnings专栏,原文如下:

Amedisys (NASDAQ:AMED) reported quarterly earnings of $0.96 per share which missed the analyst consensus estimate of $1.05 by 8.57 percent. This is a 2.13 percent increase over earnings of $0.94 per share from the same period last year. The company reported quarterly sales of $598.052 million which missed the analyst consensus estimate of $598.576 million by 0.09 percent. This is a 4.78 percent increase over sales of $570.788 million the same period last year.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法